These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

574 related articles for article (PubMed ID: 15728645)

  • 1. Intense metabolic control by means of insulin in patients with diabetes mellitus and acute myocardial infarction (DIGAMI 2): effects on mortality and morbidity.
    Malmberg K; Rydén L; Wedel H; Birkeland K; Bootsma A; Dickstein K; Efendic S; Fisher M; Hamsten A; Herlitz J; Hildebrandt P; MacLeod K; Laakso M; Torp-Pedersen C; Waldenström A;
    Eur Heart J; 2005 Apr; 26(7):650-61. PubMed ID: 15728645
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Metabolic control by means of insulin in patients with type 2 diabetes and acute myocardial infarction (DIGAMI 2): effects on mortality and morbidity--secondary publication].
    Gustafsson I; Malmberg K; Rydén L; Wedel H; Birkeland K; Bootsma A; Dickstein K; Efendic S; Fisher M; Hamsten A; Herlitz J; Hildebrandt PR; MacLeod K; Laakso M; Torp-Pedersen CT; Waldenström A;
    Ugeskr Laeger; 2006 Feb; 168(6):581-4. PubMed ID: 16476220
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Intensified insulin-based glycaemic control after myocardial infarction: mortality during 20 year follow-up of the randomised Diabetes Mellitus Insulin Glucose Infusion in Acute Myocardial Infarction (DIGAMI 1) trial.
    Ritsinger V; Malmberg K; Mårtensson A; Rydén L; Wedel H; Norhammar A
    Lancet Diabetes Endocrinol; 2014 Aug; 2(8):627-33. PubMed ID: 24831989
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prognostic implications of hypoglycaemic episodes during hospitalisation for myocardial infarction in patients with type 2 diabetes: a report from the DIGAMI 2 trial.
    Mellbin LG; Malmberg K; Waldenström A; Wedel H; Rydén L;
    Heart; 2009 May; 95(9):721-7. PubMed ID: 19029171
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The impact of glucose lowering treatment on long-term prognosis in patients with type 2 diabetes and myocardial infarction: a report from the DIGAMI 2 trial.
    Mellbin LG; Malmberg K; Norhammar A; Wedel H; Rydén L;
    Eur Heart J; 2008 Jan; 29(2):166-76. PubMed ID: 18156614
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The relationship between glycaemic variability and cardiovascular complications in patients with acute myocardial infarction and type 2 diabetes: a report from the DIGAMI 2 trial.
    Mellbin LG; Malmberg K; Rydén L; Wedel H; Vestberg D; Lind M
    Eur Heart J; 2013 Feb; 34(5):374-9. PubMed ID: 23144046
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of gender on prognosis in patients with myocardial infarction and type 2 diabetes.
    Venskutonyte L; Malmberg K; Norhammar A; Wedel H; Rydén L
    J Intern Med; 2010 Jul; 268(1):75-82. PubMed ID: 20210844
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Influence of an antidiabetic treatment with sulfonylurea drugs on long-term survival after acute myocardial infarction in patients with type 2 diabetes. The LAngendreer Myocardial infarction and Blood glucose in Diabetic patients Assessment (LAMBDA).
    Meier JJ; Deifuss S; Klamann A; Schmiegel W; Nauck MA;
    Exp Clin Endocrinol Diabetes; 2003 Sep; 111(6):344-50. PubMed ID: 14520601
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prognostic implications of glucose-lowering treatment in patients with acute myocardial infarction and diabetes: experiences from an extended follow-up of the Diabetes Mellitus Insulin-Glucose Infusion in Acute Myocardial Infarction (DIGAMI) 2 Study.
    Mellbin LG; Malmberg K; Norhammar A; Wedel H; Rydén L;
    Diabetologia; 2011 Jun; 54(6):1308-17. PubMed ID: 21359582
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Role of insulin-glucose infusion in outcomes after acute myocardial infarction: the diabetes and insulin-glucose infusion in acute myocardial infarction (DIGAMI) study.
    Malmberg K
    Endocr Pract; 2004; 10 Suppl 2():13-6. PubMed ID: 15251635
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cost-effectiveness of intense insulin treatment after acute myocardial infarction in patients with diabetes mellitus; results from the DIGAMI study.
    Almbrand B; Johannesson M; Sjöstrand B; Malmberg K; Rydén L
    Eur Heart J; 2000 May; 21(9):733-9. PubMed ID: 10739728
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Glucose-lowering therapy after myocardial infarction: more questions than answers.
    Radke PW; Schunkert H
    Eur Heart J; 2008 Jan; 29(2):141-3. PubMed ID: 18199566
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Glycometabolic state at admission: important risk marker of mortality in conventionally treated patients with diabetes mellitus and acute myocardial infarction: long-term results from the Diabetes and Insulin-Glucose Infusion in Acute Myocardial Infarction (DIGAMI) study.
    Malmberg K; Norhammar A; Wedel H; Rydén L
    Circulation; 1999 May; 99(20):2626-32. PubMed ID: 10338454
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [The role of diabetes mellitus as a risk factor of acute myocardial infarction].
    Peng XR; Zhao YF; Zou DJ; Gu P
    Zhongguo Wei Zhong Bing Ji Jiu Yi Xue; 2011 Jun; 23(6):322-8. PubMed ID: 21672377
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Effects of intensive insulin therapy after an acute myocardial infarction in patients with type 2 diabetes: results of the DIGAMI-2 trial].
    Scheen AJ; Radermecker RP; Philips JC
    Rev Med Liege; 2004 Sep; 59(9):534-9. PubMed ID: 15559444
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Type 2 diabetes mellitus and coronary heart disease].
    Brändle M; Amann FW; Salomon F
    Schweiz Med Wochenschr; 1999 May; 129(18):700-6. PubMed ID: 10407943
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Impact of glycaemic control, hypertension and insulin treatment on general and cause-specific mortality: an Italian population-based cohort of type II (non-insulin-dependent) diabetes mellitus.
    Bruno G; Merletti F; Boffetta P; Cavallo-Perin P; Bargero G; Gallone G; Pagano G
    Diabetologia; 1999 Mar; 42(3):297-301. PubMed ID: 10096781
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Association of dysglycemia and all-cause mortality across the spectrum of coronary artery disease.
    Yang SW; Zhou YJ; Tian XF; Pan GZ; Liu YY; Zhang J; Guo ZF; Chen SY; Gao ST; Du J; Jia DA; Fang Z; Hu B; Han HY; Gao F; Hu DY; Xu YY;
    Mayo Clin Proc; 2013 Sep; 88(9):930-41. PubMed ID: 24001485
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical characteristics, left and right ventricular ejection fraction, and long-term prognosis in patients with non-insulin-dependent diabetes surviving an acute myocardial infarction.
    Melchior T; Gadsbøll N; Hildebrandt P; Køber L; Torp-Pedersen C
    Diabet Med; 1996 May; 13(5):450-6. PubMed ID: 8737027
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of insulin treatment on cause-specific one-year mortality and morbidity in diabetic patients with acute myocardial infarction. DIGAMI Study Group. Diabetes Insulin-Glucose in Acute Myocardial Infarction.
    Malmberg K; Rydén L; Hamsten A; Herlitz J; Waldenström A; Wedel H
    Eur Heart J; 1996 Sep; 17(9):1337-44. PubMed ID: 8880018
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 29.